Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trialNature4 days ago
Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to Its Board of DirectorsJeffersonian Democrat2 days ago
- Newschannel 6 Wichita Falls2 days ago
Wyeth Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer, Inc. in 2009, has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by the U.S. Food and Drug Administration (FDA).
Want to work for Wyeth Pharmaceuticals? Get the best facts on Wyeth Pharmaceuticals's employee reviews, salaries, interviews, and even the culture overview here.
Wyeth Pharmaceuticals Company in Guayama Call 787-864-2994
NEW YORK & MADISON, N.J.--(BUSINESS WIRE)--Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at $50.19 per share, or a total of approximately $68 billion.